SCHEMBL6537570

SCHEMBL6537570

Cc1cnc2c(NC(=O)c3c(Cl)cccc3Cl)cccc2c1OCCCc1ccccn1

nearest known ligand 0.44

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
POLB P06746 1/20 0.44
KMT2A Q03164 2/20 0.42
RAB9A P51151 2/20 0.39
MAPT P10636 2/20 0.39
LMNA P02545 1/20 0.39
TSHR P16473 1/20 0.39
HTT P42858 1/20 0.39
SMN1; SMN2 Q16637 1/20 0.39
TYK2 P29597 3/20 0.38
JAK2 O60674 2/20 0.38
JAK1 P23458 2/20 0.38
NPC1 O15118 1/20 0.38
KDR P35968 1/20 0.38
SLC16A3 O15427 1/20 0.38
ALDH1A1 P00352 1/20 0.38
NPSR1 Q6W5P4 1/20 0.38
KDM4E B2RXH2 2/20 0.37
PABPC1 P11940 1/20 0.37
EIF4H Q15056 1/20 0.37
TP53 P04637 1/20 0.37

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6536825 0.86 MEN1 (0.42) POLBKMT2ATSHRHTTSMN1; SMN2
SCHEMBL6538153 0.85 PTGES (0.41) POLBKMT2ARAB9AHTTSMN1; SMN2
SCHEMBL6538032 0.84 THRB (0.47) KMT2ARAB9AMAPTLMNATSHR
SCHEMBL6536777 0.82 GAA (0.43) POLBKMT2ARAB9AMAPTLMNA
SCHEMBL6538353 0.82 MAPT (0.41) POLBKMT2ARAB9AMAPTLMNA
SCHEMBL6537792 0.81 GHSR (0.43) KMT2ARAB9AMAPTHTTSMN1; SMN2
SCHEMBL6538019 0.79 ALDH1A1 (0.40) POLBKMT2ARAB9AMAPTLMNA
SCHEMBL6537592 0.79 KMT2A (0.44) POLBKMT2AMAPTLMNATSHR
SCHEMBL8489729 0.78 KMT2A (0.58) POLBKMT2ARAB9AMAPTHTT
SCHEMBL6538049 0.78 POLB (0.44) POLBKMT2ARAB9AMAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0876345-B1 HETEROCYCLIC COMPOUNDS AS H+-ATPASES FUJISAWA PHARMACEUTICAL CO (JP) 2004-08-18 EP disclosed
US-6008230-A TREATING BONE DISEASES CAUSED BY ABNORMAL BONE METABOLISM IN HUMAN BEING OR ANIMALS AS THE INHIBITORS OF BONE RESORPTION OR THE INHIBITORS OF BONE METASTASIS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1999-12-28 US disclosed